Anna Martirosyan

Anna leads Strategy and Business Development at Journey Colab, a Sam Altman-backed company focused on the development and application of psychedelic therapeutics for addiction treatment through a model that aims to benefit all stakeholders. Prior to Journey Colab, Anna advised growth equity investors on investments in the healthcare and software sectors and worked with growing companies to accelerate go-to-market strategies.